Ledger.Open graph →
SEC Form D · filed March 9, 2021

Amunix Pharmaceuticals, Inc

Offering
$117.0M
Sold
$117.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

David Hirsch · South San Francisco, CADirectorJames Brush · South San Francisco, CADirectorOtello Stampacchia · South San Francisco, CADirectorRichard Heyman · South San Francisco, CADirectorAngie You · South San Francisco, CAExec · DirectorJames Topper · South San Francisco, CADirectorTrisha Millican · South San Francisco, CADirectorVolker Schellenberger · South San Francisco, CAExecUlf Ek · London, United KingdomDirectorArpan C. Shah · Tampa, FLExecBpeam Vi, LLC · Boston, MADirectorDaniel Rudin · New York, NYDirectorChristopher Curtis · New York, NYDirectorPhoung C. Vo · Tampa, FLDirectorTrung Pham · Toronto, Ontario, CanadaDirectorStanley M. Gordon · Laguna Beach, CAExec · DirectorDavid Lloyd · 215 Shuman Blvd #304, ILExec · DirectorNoland Langford · Naperville, ILDirectorNoland Langford · Naperville, ILDirectorS. D. Selznick · Boca Raton, FLDirectorPeter J. Westmeyer · Chicago, ILDirectorBlue Field Income I GP · Holladay, UTDirectorPurandar Das · Burlington, MADirectorShanthi Boppana · Burlington, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗